All Q2 FY26 results →
KP

Krishana Phoschem Ltd

Q2 FY26

Krishana Phoschem Q2 FY26: Revenue ₹2,000 Cr

Q2 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹209
Market cap₹6.5K Cr
P/E32.8
Updated16 Oct 2026
Read4 min read

The short version

Company expects similar strong performance in manufacturing and trading over the next six months, continuing momentum from H1 FY’26. The company expects to maintain similar revenue and EBITDA performance over the next six months as achieved in H1 FY’26, driven by strong manufacturing and trading businesses.

From Krishana Phoschem Ltd's Q2 FY26 earnings-call transcript · updated 16 Oct 2026.

Revenue & Sales Performance

  • Company expects similar strong performance in manufacturing and trading over the next six months, continuing momentum from H1 FY’26.
  • Trading contributes around 20%–22% of total turnover; trading volumes may vary depending on market conditions.
  • With the upcoming Meghnagar expansion (adding 1,65,000 MTPA capacity) expected by March 2026, initial utilization is estimated at 50%–55%, potentially increasing to 80%+ in subsequent years.
  • Total DAP-NPK capacity to reach 4,95,000 tonnes with expected utilization of 75%–80%.
  • Revenue potential from DAP-NPK and SSP combined could reach around ₹2,000 crore at full capacity.
  • Continued focus on strong domestic demand, government support (MSP hikes), and subsidy increases support optimistic volume and revenue growth outlook.

2 more points from Krishana Phoschem Ltd's call on revenue

Pro opens every point from 15K+ earnings calls

Profitability & Margins

See what Krishana Phoschem Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Meghnagar expansion project underway, adding 1,65,000 MTPA capacity to NPK/DAP and 99,000 MTPA to Sulfuric Acid.
  • Total investment in Meghnagar expansion is ₹142 crore.
  • Project funded through ₹75 crore term loan and internal accruals.
  • Civil work in progress, on track for commissioning by March 2026.
  • Exploring additional strategic expansions to enhance capacity and seize growth opportunities.
  • Company selected as preferred buyer of Green Ammonia (70,000 MTPA) under SECI’s SIGHT Scheme for a decade-long partnership for green raw material supply.
  • No current plan for equity infusion; future equity infusion or preferential allotment could reduce borrowings.

2 more points from Krishana Phoschem Ltd's call on capex

Pro opens every point from 15K+ earnings calls

Fundraising & Capital Structure

See what Krishana Phoschem Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript does not explicitly mention the current or expected order book or pending orders for Krishana Phoschem Limited. However, some relevant points related to demand and business outlook are: - Strong fertilizer demand driven by favorable monsoon and government policies supporting balanced nutrition and MSP hikes. - Trading contributed around 20%-22% of turnover in recent quarters, which is opportunistic based on market demand. - Manufacturing operations are running smoothly with expansion plans ongoing; new capacity of 1,65,000 tonnes expected to come online by March 2026 with initial utilization around 50%-55%. - Working capital and receivables related to trading expected to be realized within 6 months.

2 more points from Krishana Phoschem Ltd's call on order book

Pro opens every point from 15K+ earnings calls

Krishana Phoschem Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹755 Cr, net profit ₹83 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Fertilizers & Agrochemicals this season

  • Bhagiradha Chemicals & Industries Ltd (Q2 FY26)

    140.1 crore, up 35% YoY from Rs. Key investor presentation takeaways from Bhagiradha Chemicals & Industries Ltd's Q2 FY26 investor presentation — and how it ran

  • Sumitomo Chemi. (Q2 FY26)

    Domestic sales grew 11% YoY in H1 FY '25-'26, with improved farmer connect initiatives like 'Every Day Farmers Day' enhancing demand. Key concall takeaways…

  • Chambal Fertilisers & Chemicals Ltd (Q2 FY26)

    Crop Protection and Speciality Nutrients show strong traction with a 28-29% year-on-year revenue growth and 37% growth in contribution margins; 22 new products…

  • Anya Polytech & (Q2 FY26)

    Packaging segment EBITDA margin is around 10%-12%, while fertilizer segment EBITDA margin is about 20%. Key concall takeaways from Anya Polytech &'s Q2 FY26…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Krishana Phoschem Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Krishana Phoschem Ltd Q2 FY26 results?

Company expects similar strong performance in manufacturing and trading over the next six months, continuing momentum from H1 FY’26. The company expects to maintain similar revenue and EBITDA performance over the next six months as achieved in H1 FY’26, driven by strong manufacturing and trading businesses.

What is Krishana Phoschem Ltd share price analysis?

Krishana Phoschem Ltd currently shows a neutral. The stock trades at a P/E of 32.8 with a market cap of ₹6,452 Cr. Investors should review the full earnings analysis for detailed insights.

Is Krishana Phoschem Ltd planning capital expenditure?

Meghnagar expansion project underway, adding 1,65,000 MTPA capacity to NPK/DAP and 99,000 MTPA to Sulfuric Acid.

Keep Krishana Phoschem Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.